
==== Front
BMC Infect Dis
BMC Infect Dis
BMC Infectious Diseases
1471-2334
BioMed Central London

39245722
9843
10.1186/s12879-024-09843-7
Research
Clinical characterization of brucellosis in children from non-pastoral areas: a report of five cases
Lin Yuan
Peng Qin
Chen Biquan Defin0918@outlook.com

https://ror.org/04je70584 grid.489986.2 0000 0004 6473 1769 Department of Infectious Diseases, Anhui Provincial Children’s Hospital, Hefei, 230001 China
8 9 2024
8 9 2024
2024
24 92916 5 2024
30 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Background

Brucellosis is a global public health concern and occurs mainly in young adults and the elderly, with children having a lower incidence, thus often leading to delayed treatment. This study aimed to describe the epidemiologic features and clinical characteristics of brucellosis in children.

Methods

In this retrospective study, the clinical data of five children diagnosed with brucellosis in Anhui Provincial Children’s Hospital between January 1, 2021 and December 30, 2022 were analyzed.

Results

All five cases were from non-pastoral areas, among which three have a history of livestock exposure and originated from the countryside. All patients had medium-high grade fever, mostly accompanied by night sweats and malaise, and three had joint pains. Laboratory tests showed that their white blood cell count was normal or mildly raised, with lymphocytes as the predominant cell population. Four patients had anemia, four had aspartate aminotransferase and alanine aminotransferase abnormality, and two had elevated ferritin levels. All blood samples were positive for Brucella culture, one of which had positive bone marrow culture, and all had positive serology test results. All patients were treated with rifampicin, in combination with sulfamethoxazole or doxycycline for 6 weeks following diagnosis. Four children had a good prognosis, but one child had recurrent joint pain.

Conclusions

The epidemiologic history of children from non-pastoral areas with brucellosis is often unclear; clinical manifestations and laboratory tests lack specificity; and they are easily delayed diagnosis. Clinicians should remain vigilant regarding the possibility of this disease in children with fever of unknown origin. The epidemiological history should be investigated in detail to improve the diagnostic ability of brucellosis. We recommend emphasizing serological testing. Children with brucellosis who receive timely diagnosis and standardized treatment can expect a favorable prognosis.

Keywords

Brucellosis
Epidemiologic
Fever
Non-pastoral areas
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

Brucellosis is a serious zoonotic infection disease that is endemic worldwide. It causes serious economic loss and is a threat to public health, contributing to a heavy burden of disease globally [1, 2]. Its prevalence has been gradually declining in traditionally high prevalence areas, such as the Mediterranean Basin, France, and Latin America; however, epidemics and outbreaks occur in several countries, particularly in the countries of the Near East, and Central Asia, Furthermore, the disease is still in varying trends, both in European countries and in the USA [3]. In 2013–2017, the annual incidence ranged from approximately 0.0301–0.2357/100.000 in Anhui province and has been increasing yearly in recent years [4]. The common clinical manifestations of brucellosis include fever, fatigue, and joint and muscle pain, leading to multiple system damage [5] and showing a wide range of clinical polymorphisms that mimic many diseases. Epidemiology is often not easy to trace owing to the limited range of movement of children, particularly in those originating from non-pastoral areas, resulting in a high rate of misdiagnosis, treatment delay, and increased incidence of chronic illness and complications. Herein, we summarize the epidemiological and clinical characteristics of five children diagnosed with brucellosis who were admitted to our hospital and provide a review of the literature to enhance the diagnostic rate of brucellosis and ensure timely treatment.

Methods

This retrospective and descriptive study was conducted on five children with brucellosis admitted to our hospital between January 1, 2021 and December 30, 2022. Microsoft Excel 2019 was used to collect the data from the hospital information system, including demographic information, clinical manifestations, laboratory examination results (complete blood count, hemoglobin level, platelet count, erythrocyte sedimentation rate, C-reactive protein, procalcitonin, ferritin, aminotransferase, blood and bone marrow cultures, bone marrow cytology), and cervical lymph node B-ultrasound, abdominal B-ultrasound, joint magnetic resonance imaging (MRI).

Brucellosis was diagnosed based on China’s national guideline for the “Diagnosis for Brucellosis [6].” First, clinical manifestations, such as fever, sweating, fatigue, and joint pain, were assessed. Second, the presence of Brucella spp. in blood or bone marrow culture was determined. The Bac-Tac blood-culture system(BACT/ALERT® 3D, BioMérieux) was used for determining the results of the blood or bone marrow culture, and the VITEK2 compact system(BioMérieux, China) was used for bacteria identification after Gram staining.

Results

General information and epidemiology

All five patients were from non-pastoral areas of the Anhui province, with ages ranging from 2 to 12 years, with three cases living in rural areas. Disease onset was in spring and summer. Four of the five patients were male. Three children had a history of sheep contact, one ate sheep meat, and one had no history of suspicious contact with animals or consumption of animal and dairy products (Table 1).

Clinical characteristics

The initial symptom was medium- to high-grade fever, the pattern of which was not fixed. The course of the disease was mostly accompanied by night sweats, fatigue, and poor appetite. Three cases reported joint pain (Case 3: hip, knee, and ankle; Case 4: hip and knee; Case 5: shoulder, hip, and knee). Physical examination showed enlargement of the cervical lymph nodes and liver/spleen in all children (Table 1).

Table 1 General information and clinical characteristics of 5 children with brucellosis

Case	Sex	Age	Form	Month of onset	Transmission route	Chief complaint	Joint pain	Accompanying	Misdiagnose	
1	Male	5y	Rural	May	Direct contact	Fever for 13 days	Without	Sweats, Fatigue	No	
2	Male	11y	Rural	July	Direct contact	Fever for 7 days	Without	Profuse sweating	No	
3	Male	12y	Urban	May	Undefined	Intermittent fever for more than 1 month	Recurrent	No	Yes	
4	Female	7y	Rural	July	Direct contact	Intermittent fever for more than 3 months	Transient	Sweats, Fatigue	Yes	
5	Male	2y5m	Urban	April	Digestive tract	Fever for half a month	Transient	Sweats, Fatigue	No	

Auxiliary examination

The white blood cell count was normally or mildly elevated, with lymphocytes as the predominant cell population. The serum levels of C-reactive protein and procalcitonin were normal or mildly raised (Table 2). Four cases had anemia, one had thrombocytopenia, four had elevated ferritin levels (> 150 ng/mL), and four had liver function abnormalities. Blood cultures were positive in five cases, including one with a positive bone marrow culture. Imaging findings detected hepatomegaly in three cases, splenomegaly in five, and enlarged cervical lymph nodes in five (> 1.5 cm). MRI revealed joint cavity effusion in two patients who had transient joint symptoms, one patient with recurrent joint pain developed cortex of bone damage at follow-up. (Fig. 1).

Table 2 Laboratory examination of 5 children with brucellosis

Case	WBC
(×109/L)	L
(%)	HB
(g/L)	PLT
(×1012/L)	ALT/AST
(U/L)	SF
(ng/ml)	ESR
(mm/h)	CRP
(mg/dl)	PCT
(ng/ml)	Bone marrow culture	
1	13.52	76	93	80	43/91	1300.6	30	52.4	0.28	Negative	
2	6.46	48.14	90	169	153/130	780.0	25	17.9	0.514	-	
3	4.57	50.8	124	137	20/25	370.0	17	4.3	0.19	-	
4	5.77	69.5	111	245	330/409	75.4	17	7.34	0.08	-	
5	6.42	67	87	159	72/117	375.9	17	9.5	0.05	Positive	

Fig. 1 MRI scan images. A/B/C: High T2 signals in the sacroiliac joints(the dates were June 2021 / July 2022 / January 2023, respectively) of case 3. D: Joint cavity effusion in hip joint of case 5. E: Joint cavity effusion in the knee joint of case 5

Treatment and follow-up

For 6 weeks, oral rifampicin combined with doxycycline was prescribed in children aged more than 8 years, while oral rifampicin combined with cotrimoxazole was prescribed in those aged less than 8 years. This treatment course achieved satisfactory results. No severe adverse drug reactions were reported. One child (Case 5) had persistent neutropenia, which gradually returned to normal 2 weeks after treatment completion. At 1-year follow-up, four children were completely cured, but one child (Case 3) had multiple episodes of joint pain, which was relieved by supportive treatment with antibacterial drugs for 4 months. Later, intermittent joint pain was reported, and this was treated regularly with non-steroidal anti-inflammatory drugs and biologics in the rheumatology department.

Discussion

Brucellosis is the most common zoonotic infectious disease worldwide caused by infection with the bacterium Brucella, It is transmitted to humans through host animals such as sheep, cattle, camels, and even amphibians, thus affecting human health and the livestock industry [7, 8]. In China, human brucellosis occurs mainly in the northern region where livestock farming is well-developed, including Inner Mongolia, Ningxia, and Liaoning [9, 10]. With the development of animal husbandry, transportation, and tourism, the incidence of the disease increased significantly in the south coast and southwest region [11, 12]. The epidemic gradually spread from pastoral and semi-pastoral areas to urban and rural areas; however, the northern region remains the center of the epidemic.

Brucella is mainly transmitted through contact with infected animals, including goats, cattle, and pigs, or animal excrement and consumption of unpasteurized animal and dairy products [13, 14]. Occasionally, inhaling infectious aerosols carrying Brucella may cause the disease, which is a primary cause of laboratory-acquired infections [15]. An intrauterine infection route and person-to-person transmission have also been reported [16, 17]. There has been a shift in the transmission pattern of brucellosis from direct contact to food-borne. In children, it is more often transmitted through the digestive tract [18]; however, the epidemiologic history cannot be traced clearly in most patients, making diagnosis extremely difficult [19]. In this study, three of the five children lived in rural areas and had a history of animal exposure, i.e., playing with sheep. However, we did not screen the animals that came in contact with the children for brucellosis; thus, the infection sources could not be completely identified. We suggest that brucellosis screening of animals that came into contact with the patient is necessary. By contrast, the other two patients lived in the city, with good sanitary and hygienic conditions, and had no history of animal contact before the onset of the disease. We suspected that they may have been infected through the gastrointestinal route. No guardian of the children infected with Brucellosis was identified. Moreover, most patients in this study were boys. We attributed this to the fact that boys have a wider range of activities and are, therefore, more likely to be exposed to animals. A detailed epidemiologic history, including the surrounding living conditions and eating habits, should be obtained when brucellosis is suspected; however, this should not be limited to a history of animal contact but also include the meat and dairy products consumed that may have been contaminated by the bacteria. The diagnosis of brucellosis should not be excluded in the absence of a definite history of exposure, which may result in misdiagnosis.

Brucellosis is a multisystem disease, with nonspecific clinical symptoms including fever, malaise, night sweats, and myalgia arthralgia [20]. Fever is the most frequent symptom; however, owing to the extensive abuse of antimicrobial drugs, the typical undulant fever is uncommonly observed. Two misdiagnosed children were treated with multiple antibiotics, including cefuroxime, cefazoxime, amoxicillin clavulanate potassium, and azithromycin, before a definitive diagnosis was made. However, owing to the specific pathogenesis of Brucella, once the pathogen enters the macrophage system, the clinical symptoms may be relieved, presenting only as an intermittent pattern of fever, thereby creating the clinical illusion that the treatment is effective. Arthritic symptoms are less common in children than in adults and tend to involve peripheral joints, especially the knee and hip joints [21]. In this study, all five patients had a fever, accompanied by different extents of malaise and night sweats. Three children had joint pain and dyskinesia, with joint effusion shown by magnetic resonance imaging. All cases had lymph node and liver/spleen enlargement, which are more common in children than in adults since the former have underdeveloped immune systems that are more likely to be affected [22]. Recurrent fever is the most common cause of clinical visits among children, and the other signs and symptoms are not specific, especially in patients originating from non-endemic areas. These cases can be easily overlooked by clinicians, leading to misdiagnosis. Therefore, pediatricians should consider brucellosis among children with fever of unknown origin.

Patients with brucellosis can have abnormal laboratory test results, with anemia, leukopenia, thrombocytopenia, elevated liver enzymes, and elevated CRP as the most commonly reported in acute and subacute cases [23, 24]. However, because laboratory test results are usually variable and nonspecific, they cannot help clinicians in making a diagnosis, especially in the absence of epidemiologic data. Culture isolation of Brucella abortus is the gold standard for the diagnosis of brucellosis [25]. Blood is the most commonly used material for bacterial culture. In this study, all patients had a positive blood culture for Brucella melitensis, thus confirming the diagnosis; however, two patients were misdiagnosed at the first admission due to negative blood culture results and misidentification as Micrococcus garcinia, respectively. As the infection proceeds, isolation of pathogenic bacteria from blood specimens becomes increasingly difficult, as the pathogen enters the macrophage system [26]; therefore, early specimen collection is essential. Positive rates may be increased by culture of macrophage-rich tissues, such as bone marrow, liver, and lymph nodes, especially in patients living in areas with high antibiotic use and those with chronic cases [27]. Acquisition of these specimens can be invasive and painful. Furthermore, microbiologists should have sufficient experience to avoid misidentification, as Brucella is a small, short Gram-negative bacterium [28, 29]. Many factors, such as time of culture, initial infection, and recurrence, affect the rate of positivity for Brucella cultures. Because of such limitations of Brucella blood culture, complete reliance on culture results may increase the likelihood of misdiagnosis.

Compared with traditional detection methods, multiplex nucleic acid amplification technology is a more convenient and effective diagnosis technique for brucellosis [30, 31]. Serologic tests are the most widely used due to their simplicity, rapidity, and inexpensiveness in developing countries [32–34]. Frequently used serologic methods for brucellosis include the Rose Bengal test (RBT), standardized tube agglutination (SAT), and enzyme-linked immunosorbent assay (ELISA)-IgM/G. SAT can detect positive cases as early as the second week after the onset of illness and has a high level of specificity [35, 36]. Compared to the SAT, the ELISA-IgM/G has better diagnostic specificity and sensitivity, especially in chronic cases [37]. The RBT is a simple and rapid screening method usually used in epidemiological studies [38]. However, serologic tests are influenced by the patient’s immune response and cannot, therefore, provide direct evidence of microbial infection. Hence, combined serologic tests are recommended to avoid overdiagnosis and unnecessary antimicrobial therapy and should be interpreted according to clinical situations. In this study, serologic examination was performed in all five children after diagnosis, and all showed positive findings. Because of limited experience, we had not considered the possibility of brucellosis initially and did not send for serological tests, resulting in misdiagnosis in two children. Because it is economical and yields rapid results, serological testing should be performed in children with fever of unknown origin who are suspected of brucellosis. This recommendation may improve diagnostic accuracy by combining serologic testing.

Most brucellosis cases have a benign course, and timely and standardized treatment can achieve satisfactory results. However, Brucella may escape attack by the host’s innate and adaptive immune response and remain in host cells for long periods, making the treatment difficult and not easily removable [39, 40]. When therapy is delayed, the disease can become chronic or lead to serious complications, among which osteoarticular involvement is the most common [19]. All five cases in this study were treated according to the recommendations of the World Health Organization [41], achieving satisfactory therapeutic outcomes. One patient who was misdiagnosed reported recurrent joint pains in the knee, ankle, and hip joints, which caused serious disruption to his life and studies. Thus, timely diagnosis and standardized treatment are of great significance to improve disease prognosis.

Conclusions

Because the epidemiology of brucellosis in children is difficult to trace in non-pastoral areas and cases have diverse and non-specific clinical symptoms, it can be easily misdiagnosed. Thus, in treating children with fever of unknown origin, pediatricians should review their epidemiological history in detail and perform combined serologic examinations to improve the diagnosis rate to reduce the complications and burden of disease. Timely and accurate diagnosis and treatment are crucial to improve prognosis.

Acknowledgements

We thank all the doctors at the Anhui Provincial Children’s Hospital for their help in conducting this study. We also thank EditorBar (https://www.editorbar.com) for language assistance in preparing this manuscript.

Author contributions

LY and PQ collected the detailed patient data and conducted the clinical follow-up. LY drafted the manuscript. CBQ provided revision suggestions. All authors read and approved the final manuscript.

Funding

Not applicable.

Data availability

The dataset supporting the conclusions of this article is included in the article.

Declarations

Ethics approval and consent to participate

The study procedures were reviewed and approved by the ethics committee of Anhui Provincial Children’s Hospital. Informed consent was waived owing to the retrospective nature of the study.

Competing interests

The authors declare no competing interests.

Abbreviations

ELISA Enzyme-linked immunosorbent assay

MRI Magnetic resonance imaging

RBT Rose Bengal test

SAT Standardized tube agglutination

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Noguera ZL Charypkhan D Hartnack S Torgerson PR Rüegg SR The dual burden of animal and human zoonoses: a systematic review PLoS Negl Trop Dis 2022 16 10 e0010540 10.1371/journal.pntd.0010540 36240240
Noguera ZL, Charypkhan D, Hartnack S, Torgerson PR, Rüegg SR. The dual burden of animal and human zoonoses: a systematic review. PLoS Negl Trop Dis. 2022;16(10):e0010540.36240240 10.1371/journal.pntd.0010540
2. Li LM Wang Q Shi JF Li T Zhao B Ma QX Liu HY Su N Cai RP Zeng FL Seroprevalence and potential risk factors of brucellosis in sheep from America, Africa and Asia regions: a systematic review and meta-analysis Res Vet Sci 2023 165 105048 10.1016/j.rvsc.2023.105048 37866007
Li LM, Wang Q, Shi JF, Li T, Zhao B, Ma QX, Liu HY, Su N, Cai RP, Zeng FL, et al. Seroprevalence and potential risk factors of brucellosis in sheep from America, Africa and Asia regions: a systematic review and meta-analysis. Res Vet Sci. 2023;165:105048.37866007 10.1016/j.rvsc.2023.105048
3. Pappas G Papadimitriou P Akritidis N Christou L Tsianos EV The new global map of human brucellosis Lancet Infectiou s Dis 2006 6 2 91 9 10.1016/S1473-3099(06)70382-6
Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infectiou s Dis. 2006;6(2):91–9.10.1016/S1473-3099(06)70382-6
4. Xu D Song DD Wu JB Sun L Gong L Epidemiological and clinical characteristics of human brucellosis in Anhyi.2013–2017 Mod Prev Med 2018 45 23 4240 2
Xu D, Song DD, Wu JB, Sun L, Gong L. Epidemiological and clinical characteristics of human brucellosis in Anhyi.2013–2017. Mod Prev Med. 2018;45(23):4240–2.
5. Eroglu E Kandemir B Brucellosis: evaluation of two hundred and ten cases with different clinical features Ann Acad Med Singapore 2020 49 7 462 7 10.47102/annals-acadmedsg.202053 33000109
Eroglu E, Kandemir B. Brucellosis: evaluation of two hundred and ten cases with different clinical features. Ann Acad Med Singapore. 2020;49(7):462–7.33000109 10.47102/annals-acadmedsg.202053
6. National Health Commission of the People’s Republic of China Diagnosis for brucellosis (WS 269–2019) 2019 Beijing National Health Commission of the People’s Republic of China
National Health Commission of the People’s Republic of China. Diagnosis for brucellosis (WS 269–2019). Beijing: National Health Commission of the People’s Republic of China; 2019.
7. Fiebig A, Vrentas CE, Le T, Huebner M, Boggiatto PM, Olsen SC, Crosson S. Quantification of Brucella abortus population structure in a natural host. Proc Natl Acad Sci USA 2021, 118(11).
8. Whatmore AM, Foster JT. Emerging diversity and ongoing expansion of the genus Brucella. Infection, genetics and evolution: journal of molecular epidemiology and evolutionary genetics in infectious diseases 2021, 92:104865.
9. Jia P Joyner A Human brucellosis occurrences in inner mongolia, China: a spatio-temporal distribution and ecological niche modeling approach BMC Infect Dis 2015 15 36 10.1186/s12879-015-0763-9 25644986
Jia P, Joyner A. Human brucellosis occurrences in inner mongolia, China: a spatio-temporal distribution and ecological niche modeling approach. BMC Infect Dis. 2015;15:36.25644986 10.1186/s12879-015-0763-9
10. Tao Z Chen Q Chen Y Li Y Mu D Yang H Yin W Epidemiological characteristics of human brucellosis - China, 2016–2019 China CDC Wkly 2021 3 6 114 9 34595016
Tao Z, Chen Q, Chen Y, Li Y, Mu D, Yang H, Yin W. Epidemiological characteristics of human brucellosis - China, 2016–2019. China CDC Wkly. 2021;3(6):114–9.34595016
11. Kong W Brucellosis infection increasing in Southern China Eur J Intern Med 2018 51 e16 8 10.1016/j.ejim.2018.03.004 29549979
Kong W. Brucellosis infection increasing in Southern China. Eur J Intern Med. 2018;51:e16–8.29549979 10.1016/j.ejim.2018.03.004
12. Zheng R, Xie S, Lu X, Sun L, Zhou Y, Zhang Y, Wang K. A Systematic Review and Meta-Analysis of Epidemiology and Clinical Manifestations of Human Brucellosis in China. Biomed Res Int 2018, 2018:5712920.
13. Dadar M Alamian S Tadayon K Ashford RT Whatmore AM Molecular characterization of zoonotic Brucella species isolated from animal and human samples in Iran Acta Trop 2022 229 106363 10.1016/j.actatropica.2022.106363 35149040
Dadar M, Alamian S, Tadayon K, Ashford RT, Whatmore AM. Molecular characterization of zoonotic Brucella species isolated from animal and human samples in Iran. Acta Trop. 2022;229:106363.35149040 10.1016/j.actatropica.2022.106363
14. Fritz CL Nguyen A Vugia DJ Epidemiology of brucellosis in California, 1993–2017: a Continuing Foodborne Disease Risk for older latinos Clin Infect Dis 2021 73 11 2023 30 10.1093/cid/ciab551 34134141
Fritz CL, Nguyen A, Vugia DJ. Epidemiology of brucellosis in California, 1993–2017: a Continuing Foodborne Disease Risk for older latinos. Clin Infect Dis. 2021;73(11):2023–30.34134141 10.1093/cid/ciab551
15. Zhou C Huang W Xiang X Qiu J Xiao D Yao N Shu Q Zhou S Outbreak of occupational Brucella infection caused by live attenuated Brucella vaccine in a biological products company in Chongqing, China, 2020 Emerg Microbes Infections 2022 11 1 2544 52 10.1080/22221751.2022.2130099
Zhou C, Huang W, Xiang X, Qiu J, Xiao D, Yao N, Shu Q, Zhou S. Outbreak of occupational Brucella infection caused by live attenuated Brucella vaccine in a biological products company in Chongqing, China, 2020. Emerg Microbes Infections. 2022;11(1):2544–52.10.1080/22221751.2022.2130099
16. Giannacopoulos I Eliopoulou MI Ziambaras T Papanastasiou DA Transplacentally transmitted congenital brucellosis due to Brucella abortus J Infect 2002 45 3 209 10 10.1053/jinf.2002.1043 12387783
Giannacopoulos I, Eliopoulou MI, Ziambaras T, Papanastasiou DA. Transplacentally transmitted congenital brucellosis due to Brucella abortus. J Infect. 2002;45(3):209–10.12387783 10.1053/jinf.2002.1043
17. Tuon FF Gondolfo RB Cerchiari N Human-to-human transmission of Brucella - a systematic review Trop Med Int Health: TM IH 2017 22 5 539 46 10.1111/tmi.12856 28196298
Tuon FF, Gondolfo RB, Cerchiari N. Human-to-human transmission of Brucella - a systematic review. Trop Med Int Health: TM IH. 2017;22(5):539–46.28196298 10.1111/tmi.12856
18. Pourakbari B Abdolsalehi M Mahmoudi S Banar M Masoumpour F Mamishi S Epidemiologic, clinical, and laboratory characteristics of childhood brucellosis: a study in an Iranian children’s referral hospital Wien Med Wochenschr 2019 169 9–10 232 9 10.1007/s10354-019-0685-z 30778882
Pourakbari B, Abdolsalehi M, Mahmoudi S, Banar M, Masoumpour F, Mamishi S. Epidemiologic, clinical, and laboratory characteristics of childhood brucellosis: a study in an Iranian children’s referral hospital. Wien Med Wochenschr. 2019;169(9–10):232–9.30778882 10.1007/s10354-019-0685-z
19. Buzgan T Karahocagil MK Irmak H Baran AI Karsen H Evirgen O Akdeniz H Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature Int J Infect Dis 2010 14 6 e469 78 10.1016/j.ijid.2009.06.031 19910232
Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, Akdeniz H. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14(6):e469–78.19910232 10.1016/j.ijid.2009.06.031
20. Erdem H Elaldi N Ak O Gulsun S Tekin R Ulug M Duygu F Sunnetcioglu M Tulek N Guler S Genitourinary brucellosis: results of a multicentric study Clin Microbiol Infect 2014 20 11 O847 853 10.1111/1469-0691.12680 24831227
Erdem H, Elaldi N, Ak O, Gulsun S, Tekin R, Ulug M, Duygu F, Sunnetcioglu M, Tulek N, Guler S, et al. Genitourinary brucellosis: results of a multicentric study. Clin Microbiol Infect. 2014;20(11):O847–853.24831227 10.1111/1469-0691.12680
21. Ma L Ma J Chen X Dong L A 10-year retrospective comparative analysis of the clinical features of brucellosis in children and adults J Infect Developing Ctries 2021 15 8 1147 54 10.3855/jidc.13962
Ma L, Ma J, Chen X, Dong L. A 10-year retrospective comparative analysis of the clinical features of brucellosis in children and adults. J Infect Developing Ctries. 2021;15(8):1147–54.10.3855/jidc.13962
22. Gür A Geyik MF Dikici B Nas K Cevik R Sarac J Hosoglu S Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey Yonsei Med J 2003 44 1 33 44 10.3349/ymj.2003.44.1.33 12619173
Gür A, Geyik MF, Dikici B, Nas K, Cevik R, Sarac J, Hosoglu S. Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey. Yonsei Med J. 2003;44(1):33–44.12619173 10.3349/ymj.2003.44.1.33
23. Jiang W Chen J Li Q Jiang L Huang Y Lan Y Li Y Epidemiological characteristics, clinical manifestations and laboratory findings in 850 patients with brucellosis in Heilongjiang Province, China BMC Infect Dis 2019 19 1 439 10.1186/s12879-019-4081-5 31109292
Jiang W, Chen J, Li Q, Jiang L, Huang Y, Lan Y, Li Y. Epidemiological characteristics, clinical manifestations and laboratory findings in 850 patients with brucellosis in Heilongjiang Province, China. BMC Infect Dis. 2019;19(1):439.31109292 10.1186/s12879-019-4081-5
24. Justman N Fruchtman Y Greenberg D Ben-Shimol S Hematologic manifestations of brucellosis in children Pediatr Infect Disease J 2018 37 6 586 91 10.1097/INF.0000000000001900 29329166
Justman N, Fruchtman Y, Greenberg D, Ben-Shimol S. Hematologic manifestations of brucellosis in children. Pediatr Infect Disease J. 2018;37(6):586–91.29329166 10.1097/INF.0000000000001900
25. Di Bonaventura G, Angeletti S, Ianni A, Petitti T, Gherardi G. Microbiological Laboratory Diagnosis of Human Brucellosis: An Overview. Pathogens (Basel, Switzerland) 2021, 10(12).
26. Głowacka P Żakowska D Naylor K Niemcewicz M Bielawska-Drózd A Brucella - Virulence factors, Pathogenesis and treatment Pol J Microbiol 2018 67 2 151 61 10.21307/pjm-2018-029 30015453
Głowacka P, Żakowska D, Naylor K, Niemcewicz M, Bielawska-Drózd A. Brucella - Virulence factors, Pathogenesis and treatment. Pol J Microbiol. 2018;67(2):151–61.30015453 10.21307/pjm-2018-029
27. Mantur BG Mulimani MS Bidari LH Akki AS Tikare NV Bacteremia is as unpredictable as clinical manifestations in human brucellosis Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis 2008 12 3 303 7
Mantur BG, Mulimani MS, Bidari LH, Akki AS, Tikare NV. Bacteremia is as unpredictable as clinical manifestations in human brucellosis. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2008;12(3):303–7.
28. Yang J Ren XQ Chu ML Meng DY Xue WC Mistaken identity of Brucella infection J Clin Microbiol 2013 51 6 2011 10.1128/JCM.03222-12 23447630
Yang J, Ren XQ, Chu ML, Meng DY, Xue WC. Mistaken identity of Brucella infection. J Clin Microbiol. 2013;51(6):2011.23447630 10.1128/JCM.03222-12
29. Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev 2019, 33(1).
30. Dal T Kara SS Cikman A Balkan CE Acikgoz ZC Zeybek H Uslu H Durmaz R Comparison of multiplex real-time polymerase chain reaction with serological tests and culture for diagnosing human brucellosis J Infect Public Health 2019 12 3 337 42 10.1016/j.jiph.2018.11.008 30553722
Dal T, Kara SS, Cikman A, Balkan CE, Acikgoz ZC, Zeybek H, Uslu H, Durmaz R. Comparison of multiplex real-time polymerase chain reaction with serological tests and culture for diagnosing human brucellosis. J Infect Public Health. 2019;12(3):337–42.30553722 10.1016/j.jiph.2018.11.008
31. Navarro E Segura JC Castaño MJ Solera J Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis Clin Infect Diseases: Official Publication Infect Dis Soc Am 2006 42 9 1266 73 10.1086/503035
Navarro E, Segura JC, Castaño MJ, Solera J. Use of real-time quantitative polymerase chain reaction to monitor the evolution of Brucella melitensis DNA load during therapy and post-therapy follow-up in patients with brucellosis. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2006;42(9):1266–73.10.1086/503035
32. Xu N Wang W Chen F Li W Wang G ELISA is superior to bacterial culture and agglutination test in the diagnosis of brucellosis in an endemic area in China BMC Infect Dis 2020 20 1 11 10.1186/s12879-019-4729-1 31906870
Xu N, Wang W, Chen F, Li W, Wang G. ELISA is superior to bacterial culture and agglutination test in the diagnosis of brucellosis in an endemic area in China. BMC Infect Dis. 2020;20(1):11.31906870 10.1186/s12879-019-4729-1
33. Ekiri AB, Kilonzo C, Bird BH, VanWormer E, Wolking DJ, Smith WA, Masanja H, Kazwala RR, Mazet JAK. Utility of the Rose Bengal Test as a Point-of-Care Test for Human Brucellosis in Endemic African Settings: A Systematic Review. Journal of tropical medicine 2020, 2020:6586182.
34. Alumasa L Thomas LF Amanya F Njoroge SM Moriyón I Makhandia J Rushton J Fèvre EM Falzon LC Hospital-based evidence on cost-effectiveness of brucellosis diagnostic tests and treatment in Kenyan hospitals PLoS Negl Trop Dis 2021 15 1 e0008977 10.1371/journal.pntd.0008977 33411798
Alumasa L, Thomas LF, Amanya F, Njoroge SM, Moriyón I, Makhandia J, Rushton J, Fèvre EM, Falzon LC. Hospital-based evidence on cost-effectiveness of brucellosis diagnostic tests and treatment in Kenyan hospitals. PLoS Negl Trop Dis. 2021;15(1):e0008977.33411798 10.1371/journal.pntd.0008977
35. Araj GF Update on laboratory diagnosis of human brucellosis Int J Antimicrob Agents 2010 36 Suppl 1 S12 17 10.1016/j.ijantimicag.2010.06.014 20692128
Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36(Suppl 1):S12–17.20692128 10.1016/j.ijantimicag.2010.06.014
36. Qiangsheng F Xiaoqin H Tong L Wenyun G Yuejuan S Brucella cultures characteristics, clinical characteristics, and infection biomarkers of human brucellosis J Infect Public Health 2023 16 3 303 9 10.1016/j.jiph.2023.01.002 36641837
Qiangsheng F, Xiaoqin H, Tong L, Wenyun G, Yuejuan S. Brucella cultures characteristics, clinical characteristics, and infection biomarkers of human brucellosis. J Infect Public Health. 2023;16(3):303–9.36641837 10.1016/j.jiph.2023.01.002
37. Khan MZ, Zahoor M. An Overview of Brucellosis in Cattle and Humans, and its Serological and Molecular Diagnosis in Control Strategies. Tropical medicine and infectious disease 2018, 3(2).
38. Díaz R Casanova A Ariza J Moriyón I The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease PLoS Negl Trop Dis 2011 5 4 e950 10.1371/journal.pntd.0000950 21526218
Díaz R, Casanova A, Ariza J, Moriyón I. The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease. PLoS Negl Trop Dis. 2011;5(4):e950.21526218 10.1371/journal.pntd.0000950
39. de Figueiredo P Ficht TA Rice-Ficht A Rossetti CA Adams LG Pathogenesis and immunobiology of brucellosis: review of Brucella- host interactions Am J Pathol 2015 185 6 1505 17 10.1016/j.ajpath.2015.03.003 25892682
de Figueiredo P, Ficht TA, Rice-Ficht A, Rossetti CA, Adams LG. Pathogenesis and immunobiology of brucellosis: review of Brucella- host interactions. Am J Pathol. 2015;185(6):1505–17.25892682 10.1016/j.ajpath.2015.03.003
40. Pellegrini JM, Gorvel JP, Memet S. Immunosuppressive mechanisms in Brucellosis in Light of Chronic Bacterial diseases. Microorganisms 2022, 10(7).
41. WHO, OIE, FAO., Brucellosis in humans and animals. In.; 2006: 36–38. Brucellosis in humans and animals.(https://www.who.int/publications/i/item/9789241547130).
